Skip to main content
. 2023 Aug 22;9(6):498–509. doi: 10.1002/cjp2.339

Figure 3.

Figure 3

OS, DSS, and DFS for (A–C) INSM1 expression groups in conventional adenocarcinomas with a non‐neuroendocrine morphology and for (D–F) INSM1 expression groups in conventional adenocarcinomas compared with MANEC/NEC.